BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24563068)

  • 1. Effect of chemotherapy on quality of life in patients with non-small cell lung cancer.
    Mannion E; Gilmartin JJ; Donnellan P; Keane M; Waldron D
    Support Care Cancer; 2014 May; 22(5):1417-28. PubMed ID: 24563068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer.
    Tanvetyanon T; Soares HP; Djulbegovic B; Jacobsen PB; Bepler G
    J Thorac Oncol; 2007 Dec; 2(12):1091-7. PubMed ID: 18090580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
    Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring quality of life: an emerging science.
    Moinpour CM
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):48-60; discussion 60-3. PubMed ID: 7973770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in and Determinants of Quality of Life in Patients With Advanced Non-Small-Cell Lung Cancer Undergoing Initial Chemotherapy.
    Dai YL; Yang CT; Chen KH; Tang ST
    J Nurs Res; 2017 Jun; 25(3):203-215. PubMed ID: 28481816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality-of-life assessment in phase III clinical trials of gemcitabine in non-small-cell lung cancer.
    Reynolds JK; Levien TL
    Drugs Aging; 2008; 25(11):893-911. PubMed ID: 18947258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality-of-life trials in lung cancer: past achievements and future challenges.
    Movsas B; Scott C
    Hematol Oncol Clin North Am; 2004 Feb; 18(1):161-86. PubMed ID: 15005287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.
    Bezjak A; Lee CW; Ding K; Brundage M; Winton T; Graham B; Whitehead M; Johnson DH; Livingston RB; Seymour L; Shepherd FA
    J Clin Oncol; 2008 Nov; 26(31):5052-9. PubMed ID: 18809617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer.
    Mohan A; Singh P; Kumar S; Mohan C; Pathak AK; Pandey RM; Guleria R
    Asian Pac J Cancer Prev; 2008; 9(4):557-62. PubMed ID: 19256738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.
    Paccagnella A; Favaretto A; Oniga F; Barbieri F; Ceresoli G; Torri W; Villa E; Verusio C; Cetto GL; Santo A; De Pangher V; Artioli F; Cacciani GC; Parodi G; Soresi F; Ghi MG; Morabito A; Biason R; Giusto M; Mosconi P; Chiarion Sileni V;
    Lung Cancer; 2004 Jan; 43(1):83-91. PubMed ID: 14698542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial.
    Moinpour CM; Lyons B; Grevstad PK; Lovato LC; Crowley J; Czaplicki K; Buckner ZM; Ganz PA; Kelly K; Gandara DR
    Qual Life Res; 2002 Mar; 11(2):115-26. PubMed ID: 12018735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC).
    Chen G; Feng J; Zhou C; Wu YL; Liu XQ; Wang C; Zhang S; Wang J; Zhou S; Ren S; Lu S; Zhang L; Hu CP; Hu C; Luo Y; Chen L; Ye M; Huang J; Zhi X; Zhang Y; Xiu Q; Ma J; Zhang L; You C
    Ann Oncol; 2013 Jun; 24(6):1615-22. PubMed ID: 23456778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of comprehensive rehabilitation program plus chemotherapy on quality of life in patients with postoperative non-small-cell lung cancer: study protocol of a multicenter randomized clinical trial.
    Yao J; Jiao L; Yao Y; Lu Y; Shi J; Li J; Chen P; Xu L; Gong Y
    Trials; 2020 Apr; 21(1):309. PubMed ID: 32245480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.
    Auchter RM; Scholtens D; Adak S; Wagner H; Cella DF; Mehta MP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1199-206. PubMed ID: 11483329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.
    Vasconcellos VF; Marta GN; da Silva EM; Gois AF; de Castria TB; Riera R
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD009256. PubMed ID: 31930743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life as a clinical trial endpoint: determining the appropriate interval for repeated assessments in patients with advanced lung cancer.
    Hollen PJ; Gralla RJ; Rittenberg CN
    Support Care Cancer; 2004 Nov; 12(11):767-73. PubMed ID: 15206013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial.
    Dancey J; Shepherd FA; Gralla RJ; Kim YS
    Lung Cancer; 2004 Feb; 43(2):183-94. PubMed ID: 14739039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Life in elderly patients with cancer.
    Di Maio M; Perrone F
    Health Qual Life Outcomes; 2003 Sep; 1():44. PubMed ID: 14525617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life Achieved by Carboplatin Plus Etoposide as Third-Line Chemotherapy Compared with Best Supportive Care in Non-Small Cell Lung Cancer Stage IIIB/IV.
    Maneechawakajorn J; Hathaisanguan S
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S175-81. PubMed ID: 27266233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Phase 3 Trial of Palliative Radiation Therapy Versus Concurrent Chemotherapy and Palliative Radiation Therapy in Patients With Good Performance Status, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer With Symptoms due to Intrathoracic Disease Who are Not Suitable for Radical Chemo-radiation Therapy: Results of the Trans-Tasman Radiation Oncology Group 11.03 Trial.
    Lehman M; Bernard A; See A; King M; Michael M
    Pract Radiat Oncol; 2021; 11(4):252-263. PubMed ID: 33271352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.